CCR2 and heart disorder: Discovered a subset of fibroblasts in cardiac disease, which causes tissue fibrosis. Their emergence results from interactions with CCR2 macrophages through IL-1β signaling. Targeting inflammation to block these interactions holds potential as a therapy to reduce cardiac fibrosis and restore organ function.